Search

Your search keyword '"Bensen, Jeannette T."' showing total 604 results

Search Constraints

Start Over You searched for: Author "Bensen, Jeannette T." Remove constraint Author: "Bensen, Jeannette T."
604 results on '"Bensen, Jeannette T."'

Search Results

3. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

4. Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24

5. Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.

6. Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24.

7. African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.

8. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry

9. Question prompt lists and caregiver question asking in pediatric specialty appointments: A randomized controlled trial

12. The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations

13. Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry

14. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

16. The motivation and process for developing a consortium‐wide time and motion study to estimate resource implications of innovations in the use of genome sequencing to inform patient care

18. Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial

19. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.

21. The motivation and process for developing a consortium‐wide time and motion study to estimate resource implications of innovations in the use of genome sequencing to inform patient care.

25. The Burden of COVID-19 on Caregivers of Children with Suspected Genetic Conditions: A Therapeutic Odyssey

26. Abstract 3508: Association between clonal hematopoiesis and risk of prostate cancer in a large sample of African ancestry men

27. Abstract 1182: Association of prostate cancer candidate genes with overall and aggressive prostate cancer in men of African ancestry

32. Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach

33. Supplementary Table S3 from Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry

34. Data from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium

35. Supplementary Table 4 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium

36. Supplementary Table 6 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium

37. Supplementary Table 1 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium

39. Supplementary Fig Leg from Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry

40. Supplementary Methods1 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium

41. Associations between statin use and prostate cancer aggressiveness, overall and stratified by race and additionally adjusted for education, income and family history of prostate cancer. from Statin Use and Prostate Cancer Aggressiveness: Results from the Population-Based North Carolina–Louisiana Prostate Cancer Project

44. Supplementary Table 3 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium

45. Supplementary Table 5 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium

49. Associations between statin use, dose and type and prostate cancer aggressiveness, overall and stratified by race, excluding men who were using non-statin cholesterol-lowering drugs. from Statin Use and Prostate Cancer Aggressiveness: Results from the Population-Based North Carolina–Louisiana Prostate Cancer Project

50. Supplementary Table 2 from Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium

Catalog

Books, media, physical & digital resources